Epstein-Barr Virus, or EBV, is one of the most common human viruses in the world; almost 95% of 35-40 year olds in the United States have been infected at some point in their life. The Epstein-Barr Virus can be contracted any time after an infant loses its maternal antibody protection. The virus can cause infectious mononucleosis in children, teens, and young adults, but some adolescents and most adults who contract the virus only experience a mild illness. After the initial infection, the Epstein-Barr Virus remains dormant in saliva and blood cells, as well as in the immune system. The virus has no cure or containment strategy, because it is transferred through saliva, even when the individual with the virus appears healthy. The newly infected individual may not show symptoms for 4 to 6 weeks, so the virus spreads easily and is difficult to contain. Epstein-Barr Virus has been linked to a few cancers, and a vaccine is currently being developed.
Epstein-barr Virus Infections Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Epstein-barr Virus Infections below!
For more information on how to use Laverne, please read the How to Guide.
We have 4365 products for the study of Epstein-barr Virus Infections that can be applied to Western Blot, Chromatin Immunoprecipitation, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Chromatin Immunoprecipitation (ChIP), Immunohistochemistry from our catalog of antibodies and ELISA kits.